Eiffel hires ex-PowderJect manager as COO
Wednesday, 15 October, 2003
Drug reengineering company Eiffel Technologies (ASX:EIF) has recruited former PowderJect technologies manager Dr Pascal Hickey as chief operating officer.
Hickey, who will be based at Eiffel's Sydney facilities, will be responsible for the company's R&D programs.
In a statement, Eiffel CEO Christine Cussen said Hickey's experience in pharmaceutical R&D would help the company further develop its technology. Hickey played a key role in the transition of PowderJect (now part of Chiron Corporation) from a small spin-off company from Oxford University to a mature and profitable company with 1500 employees, she said.
Cannabis use may double risk of cardiovascular disease death
Cannabis users have a 29% higher risk of acute coronary syndrome, a 20% higher risk of stroke,...
Space conditions can lead to periodontitis, scientists say
Living in zero gravity can lead to periodontitis — a serious condition where the gums...
Personalised brain stimulation helps treat those with depression
By tailoring transcranial magnetic stimulation to each person's unique brain structure,...
